Effectiveness in controlling bleeds and the potential for less frequent use of a treatment are two priorities people with…
Articles by Marisa Wexler, MS
People with severe hemophilia A who switch from standard to extended half-life replacement therapies experience fewer bleeds and require…
Spending on treatments for hemophilia by Medicaid, a U.S. government health insurance program for select groups, more than tripled…
Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for…
GenScript ProBio and Neoletix Biotechnology have entered into an agreement for clinical and commercial production of a lab-made version…
A first patient has been dosed in XTEND-Kids, a Phase 3 clinical trial evaluating the safety and efficacy of the…
Women who are hemophilia carriers are at a higher risk of experiencing heavy bleeding after giving birth, particularly those…
A research study is asking people with hemophilia and other inherited bleeding disorders living in the U.K., U.S., or…
People with mild to moderate hemophilia, in particular women with the disease, face unique challenges, many that are specifically…
Treatment with Octapharma‘s Nuwiq is associated with a low risk of developing inhibitors — antibodies that prevent the medication…